Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds inhibiting leucine-rich repeat kinase enzyme activity

Compounds inhibiting leucine-rich repeat kinase enzyme activity

US Patent 10954240 · Granted Mar 23, 2021

Estimated economic value: $131,140,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
C-terminal SRC kinase inhibitors2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Thyroid hormone receptor agonists2025
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine r2025
Heterocyclic compounds, preparation methods and uses thereof2025
EGFR inhibitors2025
Selective estrogen receptor degraders and uses thereof2025
Heterocyclic compounds, preparation methods therefor, and methods of uses thereo2024
Heterocyclic compounds, preparation methods and uses thereof2024
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antag2024
Inhibitor of indoleamine-2,3-dioxygenase (IDO)2024